Top 10 Healthcare Devices and Supplies Capital Raises and Investors in the U.S. – November 16th to December 31st, 2025

Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me.

PIPE

1. Positron, medical technology company that engages in the development, manufacturing, and sales of PET and PET-CT molecular imaging systems for nuclear medicine providers across North America, received $2 million of development capital from investors.
2. TELA Bio, commercial-stage medical technology that provides innovative soft-tissue reconstruction solutions and optimizes clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy, received $4.65 million of development capital from EW Healthcare Partners and Nantahala Capital Management.

Merger/Acquisition

3. Alerje, health technology solution for individuals with severe food allergies, was acquired by SemPresto.
4. Applied Tissue Technologies, wound care technologies that offer treatment of common acute and chronic wounds, was acquired by New Horizon Medical Solutions.

Later Stage VC

5. BioIntelliSense, remote patient monitoring device that enhances healthcare delivery, raised $58.05 million of venture funding.
6. eLux Medical, fat removal technology that disrupts the cosmetic surgery market, raised $11.28 million through a combination of Series B and Series B-1 venture funding from investors, putting the company’s pre-money valuation at $12 million.

Early Stage VC

7. Entirety Biomedical, high-performance absorbable metal implants that improve the quality of life with advanced bioabsorbable implant technology, raised $1.2 million of venture funding in a deal led by NuFund Venture Group, putting the company’s pre-money valuation at $8.8 million.
8. OrthoPreserve, meniscus implant device that replaces the damaged meniscus to relieve pain, restore mobility, and prevent the accelerated arthritis development that normally accompanies a meniscectomy, raised $157,000 of venture funding in the form of convertible debt financing from investors.

Seed Round

9. RedDrop Dx, device that allows blood collection to be done quickly, painlessly, and without a trained professional, raised $7 million of seed funding in a deal led by Phase Three Product Development, Stout Street Capital and Innosphere Ventures Fund.
10. TYBR Health, collagen-based resorbable hydrogel that protects healing tendons and ligaments and support recovery after surgery, raised $7.14 million through a combination of Seed Prime-1 and Seed Prime-2 funding from Johnson & Johnson Innovation – JLABS, Texas Medical Center and VentureSouq, putting the company’s pre-money valuation at $9.66 million.

#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcare #medtech #medicaltechnology #healthcaredevices #healthcaresupplies

Tamara Williams

Managing Director

Please contact me if you have any questions or would like to discuss your capital raise:

Email: twilliams@castleplacement.com

(C) (385) 600-1871

Send us a message:

Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.